Label: ONDANSETRON tablet, film coated

  • Category: HUMAN PRESCRIPTION DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: Abbreviated New Drug Application

Drug Label Information

Updated September 12, 2018

If you are a consumer or patient please visit this version.

  • DESCRIPTION

  • CLINICAL PHARMACOLOGY

  • INDICATIONS AND USAGE

    1. Prevention of nausea and vomiting associated with highly emetogenic cancer chemotherapy.
    2. Prevention of nausea and vomiting associated with initial and repeat courses of moderately emetogenic cancer chemotherapy.
    3. Prevention of nausea and vomiting associated with radiotherapy in patients receiving either total body irradiation, single high-dose fraction to the abdomen, or daily fractions to the abdomen.
    4. Prevention of postoperative nausea and/or vomiting. As with other antiemetics, routine prophylaxis is not recommended for patients in whom there is little expectation that nausea and/or vomiting will occur postoperatively. In patients where nausea and/or vomiting must be avoided postoperatively, ondansetron tablets, USP are recommended even where the incidence of postoperative nausea and/or vomiting is low.
  • CONTRAINDICATIONS

  • WARNINGS

  • ADVERSE REACTIONS

  • DRUG ABUSE AND DEPENDENCE

  • OVERDOSAGE

  • DOSAGE AND ADMINISTRATION

  • PACKAGE LABEL-PRINCIPAL DISPLAY PANEL

    ONDANESTRON 4 mg

  • PRINCIPAL DISPLAY PANEL

    10

  • INGREDIENTS AND APPEARANCE
    ONDANSETRON 
    ondansetron tablet, film coated
    Product Information
    Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:61919-565(NDC:65862-187)
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    ONDANSETRON HYDROCHLORIDE (UNII: NMH84OZK2B) (ONDANSETRON - UNII:4AF302ESOS) ONDANSETRON4 mg
    Inactive Ingredients
    Ingredient NameStrength
    ANHYDROUS LACTOSE (UNII: 3SY5LH9PMK)  
    CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  
    MAGNESIUM STEARATE (UNII: 70097M6I30)  
    STARCH, CORN (UNII: O8232NY3SJ)  
    TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  
    HYPROMELLOSE 2910 (6 MPA.S) (UNII: 0WZ8WG20P6)  
    TRIACETIN (UNII: XHX3C3X673)  
    Product Characteristics
    Colorwhite (WHITE TO OFF WHITE) Scoreno score
    ShapeOVALSize6mm
    FlavorImprint Code F;91
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:61919-565-2020 in 1 BOTTLE; Type 0: Not a Combination Product03/23/2016
    2NDC:61919-565-101 in 1 BOTTLE; Type 0: Not a Combination Product09/12/2018
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    ANDAANDA07853903/23/2016
    Labeler - DIRECT RX (079254320)
    Establishment
    NameAddressID/FEIBusiness Operations
    DIRECT RX079254320repack(61919-565)